Developments MN technology have extended the potential of the transdermal drug delivery system, holding potential to transform areas like immunization, chronic disease treatment, pain management, and real-time biomonitoring. In the upcoming decade, drug delivery procedures are expected to prioritize people's ease and self-supervision, decreasing dependence on needles and hospitals; however, supervisory synchronization, maneuver calibration, and sustained novelty will be indispensable for MNs to develop as a standard of care.
Kushwaha et al. (Sat,) studied this question.